PROMENADE: pembrolizumab for early ER-low/HER2-negative breast cancer, real-world French cohort
PROMENADE:帕博利珠单抗治疗早期ER低表达/HER2阴性乳腺癌,法国真实世界队列研究
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2025.105907
Cherifi, F; Cabel, L; Bousrih, C; Volant, E; Dalenc, F; Mery, B; Auvray Kuentz, M; Mailliez, A; Ladoire, S; de Nonneville, A; Alexandre, M; Benistant, L; Leheurteur, M; Bailleux, C; Debled, M; Frenel, J-S; Loirat, D; Bastien, E; Aussedat, Q; Bidard, F C; Aho, S; Glenet, A; Mourato-Ribeiro, J; Johnson, A; Christy, F; Emile, G